Health Canada approves BLIS K12 probiotic

By Stephen DANIELLS

- Last updated on GMT

Health Canada approves BLIS K12 probiotic

Related tags: Streptococcus, Stratum nutrition

Oral probiotic BLIS K12 has been approved for use in supplement products by Health Canada.

A Product License Application (PLA) referencing the Master File submitted by Stratum Nutrition and BLIS Technologies to the Natural and Non-Prescription Health Products Directorate (NNHPD) gained Health Canada approval.

The ingredient was then issued a Natural Product Number (NPN), allowing Canadian manufacturers and marketers to make substantial and specific label claims on their products which contain the BLIS K12 ingredient.

BLIS K12

BLIS K12 was developed by scientists at the University of Otago in New Zealand. It is a specific strain of Streptococcus salivarius​ (S. salivarius​), which secretes powerful antimicrobial molecules called BLIS: Bacteriocin-Like-Inhibitory Substances.

BLIS K12 is an oral probiotic that is said to support healthy bacteria in the mouth for long-term fresh breath and immune support.

The ingredient is part of Stratum Nutrition’s portfolio of specialty bioactive ingredients, and is currently used in over 15 products in the US marketplace.

Claims

Health Canada has approved products containing BLIS K12 to bear claim language such as, the product “promotes oral health [through the re-colonisation of the oral cavity]”​, that it is an “oral probiotic for re-colonization of the oral cavity after antibiotic treatment”​, that “following oral antimicrobial rinsing ​Streptococcus salivarius K12 supplementation helps reduce volatile sulfur compound levels (halitosis)”​, and that it “can help reduce the incidence of Streptococcal pharyngitis/tonsillitis (sore throats caused by pathogenic variants belonging to the Streptococcus genus)”.

“As arduous as the process is, each successful regulatory approval prepares the ground for the sales and marketing effort that follows,”​ said Barry Richardson, CEO of BLIS Technologies.

Kevin Ruff, PhD, Stratum’s director of scientific & regulatory affairs said that company was pleased to be able to use its regulatory expertise in North America to open up the Canadian market for BLIS K12. “We expect the strong efficacy claims that were approved to really resonate with Canadian consumers.”

Related news

Show more

Related products

show more

It’s time for HRB – A lifelong health partner

It’s time for HRB – A lifelong health partner

Morinaga Milk Industry Co., Ltd. | 19-Nov-2020 | Technical / White Paper

Consumer awareness of the importance of choosing the right probiotics that possess extensive clinical efficacy to address fundamental health problems (e.g.,...

Next-wave sports nutrition innovation today

Next-wave sports nutrition innovation today

ADM | 28-Oct-2020 | Technical / White Paper

Today’s consumers are passionate about embracing health in many aspects of their lives, starting with customizing their nutrition. Rooted in proprietary...

Biotis™ - Solutions for a good gut feeling

Biotis™ - Solutions for a good gut feeling

FrieslandCampina Ingredients | 07-Oct-2020 | Product Brochure

Discover our range of GOS (galacto-oligosaccharides) with scientifically proven effects to significantly increase levels of ‘friendly bacteria’ in the...

Related suppliers

Follow us

Products

View more

Webinars